Literature DB >> 1569956

B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

C F Voliva1, A Aronheim, M D Walker, B M Peterlin.   

Abstract

The X box in the DRA promoter of the human histocompatibility complex is required for expression of the DRA gene in B cells. We show that a B-cell factor binds to a sequence that is clearly distinguishable from binding sites for the previously described X box binding nuclear proteins RF-X, NF-X, NF-Xc, NF-S, hXBP, and AP-1. Mutations in the DRA X box that disrupt the binding of this factor result in a lower level of gene expression, as does the presence of Id (a trans-dominant regulatory protein that negatively regulates helix-loop-helix proteins). Furthermore, this factor is recognized by antibodies directed against the helix-loop-helix protein A1, a mouse homolog of the immunoglobulin enhancer binding proteins E12/E47, and it binds to sequences in other genes that were previously shown to bind these proteins. By these criteria, this factor is BCF-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569956      PMCID: PMC364410          DOI: 10.1128/mcb.12.5.2383-2390.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Class II genes of the human major histocompatibility complex. Comparisons of the DQ and DX alpha and beta genes.

Authors:  A K Jonsson; J J Hyldig-Nielsen; B Servenius; D Larhammar; G Andersson; F Jörgensen; P A Peterson; L Rask
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

2.  Class II genes of the human major histocompatibility complex. The DO beta gene is a divergent member of the class II beta gene family.

Authors:  B Servenius; L Rask; P A Peterson
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

Review 3.  Fos and Jun: the AP-1 connection.

Authors:  T Curran; B R Franza
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

4.  Class II genes of the human major histocompatibility complex. Organization and evolutionary relationship of the DR beta genes.

Authors:  G Andersson; D Larhammar; E Widmark; B Servenius; P A Peterson; L Rask
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

5.  Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line.

Authors:  P V Basta; P A Sherman; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Identification of a nuclear factor that binds to a conserved sequence of the I-A beta gene.

Authors:  A Celada; M Shiga; M Imagawa; J Kop; R A Maki
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

7.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

Authors:  W Reith; S Satola; C H Sanchez; I Amaldi; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

8.  Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency.

Authors:  C de Préval; M R Hadam; B Mach
Journal:  N Engl J Med       Date:  1988-05-19       Impact factor: 91.245

9.  An enhancer factor defect in a mutant Burkitt lymphoma cell line.

Authors:  W Koch; S Candeias; J Guardiola; R Accolla; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

Review 10.  Organ-specific autoimmunity: a 1986 overview.

Authors:  G F Bottazzo; I Todd; R Mirakian; A Belfiore; R Pujol-Borrell
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

View more
  10 in total

1.  Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.

Authors:  N Jabrane-Ferrat; J D Fontes; J M Boss; B M Peterlin
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

2.  Sequence-independent inhibition of RNA transcription by DNA dumbbells and other decoys.

Authors:  C S Lim; N Jabrane-Ferrat; J D Fontes; H Okamoto; M R Garovoy; B M Peterlin; C A Hunt
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

3.  Cell-specific expression of helix-loop-helix transcription factors encoded by the E2A gene.

Authors:  A Aronheim; R Shiran; A Rosen; M D Walker
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

4.  Mapping cis-acting defects in promoters of transcriptionally silent DQA2, DQB2, and DOB genes.

Authors:  C F Voliva; S Tsang; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein.

Authors:  X Y Zhang; N Jabrane-Ferrat; C K Asiedu; S Samac; B M Peterlin; M Ehrlich
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

6.  Ets-1 activates the DRA promoter in B cells.

Authors:  N Jabrane-Ferrat; B M Peterlin
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

7.  Locus- and allele-specific DNA-protein interactions in the HLA-DQB1 X box.

Authors:  T L Sukiennicki; L M Shewey; G T Nepom
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

8.  Intron 4 containing novel GABAB1 isoforms impair GABAB receptor function.

Authors:  Changhoon Lee; R Dayne Mayfield; R Adron Harris
Journal:  PLoS One       Date:  2010-11-18       Impact factor: 3.240

9.  The function of the octamer-binding site in the DRA promoter.

Authors:  C F Voliva; N Jabrane-Ferrat; B M Peterlin
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

10.  Affinity enrichment and functional characterization of TRAX1, a novel transcription activator and X1-sequence-binding protein of HLA-DRA.

Authors:  Y Itoh-Lindstrom; B M Peterlin; J P Ting
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.